VAERS reports by lot

GSK Hepatitis A lot 7HJ74: VAERS reports

21 VAERS reports list lot 7HJ74 as a GSK Hepatitis A vaccine, received between 2021-04-23 and 2022-12-06. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
0%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Gastrointestinal627%
Neurological314%
Cardiac / Cardiovascular314%
General / Systemic (non-local)314%
Respiratory29%
Dermatological (non-injection-site)29%
Autoimmune / Immune-mediated15%
Allergic / Anaphylactic15%
Musculoskeletal15%

Where reports came from

U.S. state of the reporter, where given (top 12).

Louisiana3
Florida3
Indiana2
Maryland2
Minnesota1
Michigan1
Illinois1
Wisconsin1
West Virginia1
Alaska1
Virginia1
Texas1

Reports by month received

2021-041
2021-061
2021-072
2021-088
2021-091
2021-121
2022-011
2022-021
2022-051
2022-081
2022-092
2022-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.